These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. Bauman KA; Wettlaufer SH; Okunishi K; Vannella KM; Stoolman JS; Huang SK; Courey AJ; White ES; Hogaboam CM; Simon RH; Toews GB; Sisson TH; Moore BB; Peters-Golden M J Clin Invest; 2010 Jun; 120(6):1950-60. PubMed ID: 20501949 [TBL] [Abstract][Full Text] [Related]
5. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. Eitzman DT; McCoy RD; Zheng X; Fay WP; Shen T; Ginsburg D; Simon RH J Clin Invest; 1996 Jan; 97(1):232-7. PubMed ID: 8550840 [TBL] [Abstract][Full Text] [Related]
6. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system]. Cao YJ; Wu YH; Liu CF Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932 [TBL] [Abstract][Full Text] [Related]
7. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Lijnen HR; Wagner EF; Collen D Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597 [TBL] [Abstract][Full Text] [Related]
8. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage. Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Fay WP Trends Cardiovasc Med; 2004 Jul; 14(5):196-202. PubMed ID: 15261892 [TBL] [Abstract][Full Text] [Related]
10. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography. Nishiuma T; Sisson TH; Subbotina N; Simon RH Am J Respir Cell Mol Biol; 2004 Nov; 31(5):552-8. PubMed ID: 15284078 [TBL] [Abstract][Full Text] [Related]
11. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Ploplis VA; Wilberding J; McLennan L; Liang Z; Cornelissen I; DeFord ME; Rosen ED; Castellino FJ Am J Pathol; 2000 Sep; 157(3):703-8. PubMed ID: 10980108 [TBL] [Abstract][Full Text] [Related]
12. Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Chuang-Tsai S; Sisson TH; Hattori N; Tsai CG; Subbotina NM; Hanson KE; Simon RH Am J Pathol; 2003 Aug; 163(2):445-52. PubMed ID: 12875966 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen contains cryptic PAI-1 binding sites that are exposed on binding to solid surfaces or limited proteolysis. Smolarczyk K; Boncela J; Szymanski J; Gils A; Cierniewski CS Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2679-84. PubMed ID: 16210568 [TBL] [Abstract][Full Text] [Related]
15. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice. Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse. Takeshita K; Yamamoto K; Ito M; Kondo T; Matsushita T; Hirai M; Kojima T; Nishimura M; Nabeshima Y; Loskutoff DJ; Saito H; Murohara T Semin Thromb Hemost; 2002 Dec; 28(6):545-54. PubMed ID: 12536348 [TBL] [Abstract][Full Text] [Related]